anne_likes_red
Senior Member
- Messages
- 1,103
Good on ya Shane. :Retro smile:
Good work!
Good work!
Now let's see if the CAA gets on board and acts in conjunction with the IACFSME to inform every XMRV researcher of the need for precise definitions of the ME/CFS cohorts.
I am looking forward to the IACFS/ME board's response and I am very pleased with Dr. Friedberg's quick response.
We ARE on board and have been talking to anyone we can about the cohort definition question! And I think the Association would gladly partner with IACFS/ME or other groups working towards the same goal on this issue.
<snip>
Are you thinking of posting an open letter or position paper or something to that affect on the website regarding the need for clear cohort descriptions and guidelines as to what they should be, and having some sort of mail-out to all researchers?
IF,
I agree, I would have liked like this out the day before yesterday (that really would have been nice). I am not familiar with how this will/should be handled to get it out (and get it right) ASAP. I really don't know how interested a journal would be if it has already been proposed as a standard by a group such as the IACFS/ME.
Shane
How about PLoS ONE? Anyone got $1350 and a business partner to recommend as the peer-reviewer? It could be out in 72 hours. :Retro winkArghhh - that black humour of mine :Retro redface: - couldn't resist).
How about PLoS ONE? Anyone got $1350 and a business partner to recommend as the peer-reviewer? It could be out in 72 hours..
January 12, 2010
Hi Shane,
We discussed your proposal at our monthly Board conference call today.
Here are the issues:
There are about 2,500 CFS peer review articles published since the mid-1980s. Classifications on the criteria you suggested (e.g., infectious onset, gradual vs. sudden onset) are reported in some papers but not in others. And the CFS definitions used vary from Holmes to Fukuda to Oxford to Reeves, etc. Review papers do attempt to group studies by various criteria (e.g., age at onset, symptom severity, etc.), but rarely do they identify commonalities that advance our understanding of subgroups, causation, outcomes, etc.
Bottom line: It is most unlikely that an over-arching classification of CFS studies will yield new information because(1) reporting is not consistent on any particular criterion; and (2) the conclusions of well-written review articles over the past 25 years have already identified to some extent what we do know about CFS.
Putting all such doubts aside, there is the question of who will undertake such an effort? This would involve a lot of volunteer time that qualified individuals do not have. These are usually full-time researchers who are in the business of getting grants for their projects. If they wish to write a review, they structure it according to their own views of what's important.
Now the good news: It was agreed that setting up study criteria for the type of data that should be collected in a standardized way in CFS studies would be a good idea and not an impossibly time consuming task. For instance, there is an effort underway to provide standard assessments for the Canadian criteria--a worthwhile effort as these criteria may better capture CFS than other definitions. This is something that will probably be addressed at our September, 2011 IACFS/ME international conference in Ottawa.
Thank you for your input.
Fred
Fred Friedberg, PhD
President
IACFS/ME
www.iacfsme.org
Dear Dr. Friedberg,
I do understand the challenges of trying to catalog even a fraction of the articles that have been written over the past 30 years on CFS.
I am pleased to here of the ongoing efforts to provide a standardized assessment for the Canadian criteria. I do appreciate that it was primarily intended for clinical use. Having a research standard based upon the Canadian criteria is a significant step in the right direction.
And while I do wish that the IACFS/ME could address the task of setting up research criteria/guidelines before the 2011 IACFS/ME conference, I do appreciate that the members are all quite busy doing their own research (these are promising times) and getting this right is more important that getting it quickly.
Again, my sincere appreciation for your quick and thoughtful response and the IACFS/ME board/s consideration.
XXXXXXXXXX
Really if you want to get something like this done - and I can't imagine Suzanne Vernon isn't thinking along these lines - talk to the CAA.
Suzanne already has the proposal from CBS. Please bear with us (the Association) until another project reaches the stage where it can be publicly disclosed. I know that sounds cryptic, but as with all research-related projects, information can only be released after a certain point in the timeline. I will provide more info when I can.
the cdc criterea have been shown to give about 66% false positives I think we need to repeat this fact incessantly
the cdc criterea have been shown to give about 66% false positives I think we need to repeat this fact incessantly
Hi,
Estimates are that using the CDC Empirical criteria leads to a patient population with as many as 38% of the patients suffering from Major Depressive Disorder, not CFS. Jason, Leonard A; et al. (2009). "Evaluating the Centers for Disease Control's Empirical Chronic Fatigue Syndrome Case Definition". Journal of Disability Policy Studies 20: 93–100.
This it for the next several days - feeling a bit better but still have a ways to go (feels tenuous). And thanks to all those that left the wonderfully supportive messages in the community lounge (yep, I peaked).
:Retro smile: